Rosuvastatin Monotherapy Improves Lipid Profile in Combined Dyslipidemia
All Patients with Type 2 Diabetes Should Be Considered for a Statin
ANDROMEDA Study Results Presented at ADA's Annual Meeting
Lipids Remain Uncontrolled in Patients with Diabetes
Statin Therapy Beneficial for Elderly Patients with Nonischemic Dilated Cardiomyopathy
Rosuvastatin Has Favorable Effects on Atherogenic Dyslipidemia in Patients with Metabolic Syndrome
Studies Explore Links Between C-reactive Protein, Metabolic Syndrome, and Cardiovascular Disease